Literature DB >> 8646875

Chromosomal mapping of the genes for the human CDK2/cyclin A-associated proteins p19 (SKP1A and SKP1B) and p45 (SKP2).

D J Demetrick1, H Zhang, D H Beach.   

Abstract

Many gene products associated with the cyclin-dependant kinases (CDKs) have been shown to regulate the active kinase complex during the transition points of the cell cycle. Some of these proteins have been implicated in human neoplasia, acting as either oncoproteins or tumour suppressors. The CDK2/cyclin A kinase complex can complex with several proteins, including p21, and PCNA or p45, p19, and p9. It was previously shown that at least two of these proteins, p19 and p45, are abnormally regulated in transformed cell lines. We describe here the mapping by fluorescence in situ hybridization of the gene for the CDK2/cyclin A-associated protein p45 (SKP2) to 5p13 and the p19-related genes p19A (SKP1A) and p19B (SKP1B) to 7q11.2 and 12p12, respectively. All three of these loci are associated with karyotypic alterations, known amplifications, or suspected tumor suppressor genes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8646875     DOI: 10.1159/000134318

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  9 in total

1.  The expression of the F-box protein Skp2 is negatively associated with p27 expression in human pituitary tumors.

Authors:  Madalina Musat; Márta Korbonits; Megan Pyle; Maria Gueorguiev; Blerina Kola; Damian G Morris; Michael Powell; Constantin Dumitrache; Catalina Poiana; Ashley B Grossman
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

2.  Effects of delayed motherhood on hippocampal gene expression in offspring rats.

Authors:  Ping Duan; Bo Li; Caifang Li; Xuefei Han; Yan Xu; Ying Xing; Wenhai Yan
Journal:  Mol Cell Biochem       Date:  2015-05-15       Impact factor: 3.396

Review 3.  F-box proteins involved in cancer-associated drug resistance.

Authors:  Jian Gong; Yuqian Zhou; Deliang Liu; Jirong Huo
Journal:  Oncol Lett       Date:  2018-04-16       Impact factor: 2.967

4.  Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.

Authors:  K Nakayama; H Nagahama; Y A Minamishima; M Matsumoto; I Nakamichi; K Kitagawa; M Shirane; R Tsunematsu; T Tsukiyama; N Ishida; M Kitagawa; K Nakayama; S Hatakeyama
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

5.  Regulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2.

Authors:  C H Yam; R W Ng; W Y Siu; A W Lau; R Y Poon
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

6.  ISG12a Restricts Hepatitis C Virus Infection through the Ubiquitination-Dependent Degradation Pathway.

Authors:  Binbin Xue; Darong Yang; Jingjing Wang; Yan Xu; Xiaohong Wang; Yuwen Qin; Renyun Tian; Shengwen Chen; Qinya Xie; Nianli Liu; Haizhen Zhu
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

Review 7.  Emerging Roles of SKP2 in Cancer Drug Resistance.

Authors:  Ting Wu; Xinsheng Gu; Hongmei Cui
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600

8.  YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes.

Authors:  Erica Lorenzetto; Monica Brenca; Mattia Boeri; Carla Verri; Elena Piccinin; Patrizia Gasparini; Federica Facchinetti; Sabrina Rossi; Giuliana Salvatore; Maura Massimino; Gabriella Sozzi; Roberta Maestro; Piergiorgio Modena
Journal:  Oncotarget       Date:  2014-05-15

9.  Polyploid giant cancer cells with budding and the expression of cyclin E, S-phase kinase-associated protein 2, stathmin associated with the grading and metastasis in serous ovarian tumor.

Authors:  Hongcheng Lv; Yang Shi; Li Zhang; Dan Zhang; Guang Liu; Zhengduo Yang; Yan Li; Fei Fei; Shiwu Zhang
Journal:  BMC Cancer       Date:  2014-08-08       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.